Suresh’s research focuses on development of new platform technology for synthesizing heterobivalent targeting FAP and PSMA and other molecular targets for imaging and treatment of prostate cancer and renal cell carcinoma. Suresh received his PhD in Organic Chemistry from the Indian Institute of Technology (IIT).
Welcome to the Ray lab's new postdoc, Dr. Suresh Alati!
Updated: Oct 9, 2023